期刊文献+

软骨发育不良一家系的FGFR3基因突变分析 被引量:5

下载PDF
导出
摘要 目的探讨一个中国汉族软骨发育不良家系的临床表型及FGFR3基因突变类型,确定其致病原因。方法在获得知情同意后对该家系成员进行病史采集和临床检测,并对其中3例患者和3例正常亲属及家系外100例正常对照者采血进行DNA提取,采用聚合酶链反应结合DNA直接测序法对FGFR3基因的第10、13外显子及其部分内含子进行突变检测。结果该家系中3例患者的临床表现为身材矮小、四肢过短、腰椎前突、头颅增大、前额突出。3例患者在FGFR3基因对应cDNA序列发现C1620A(N540K)杂合突变及第13内含子3'剪接位点上游23 bp处发现一G>A杂合突变,3例正常亲属及家系外100例正常对照者均未发现该两种突变。结论FGFR3基因的N540K突变是导致该家系软骨发育不良的关键性分子病因,而内含子IVS13-23突变可能加重了患者的病情。
出处 《广东医学》 CAS CSCD 北大核心 2012年第13期1982-1984,共3页 Guangdong Medical Journal
基金 怀化医学高等专科学校教科研资助项目(编号:2010KY04)
  • 相关文献

参考文献12

  • 1ALMEIDA M R, CAMPOS XAVIER A B, MEDEIRA A, et al. Clinical and molecular diagnosis of the skeletal dysplasias associat- ed with mutations in the gene encoding Fibroblast Growth Factor Receptor 3 ( FGFR3 ) in Portugal [ J ]. Clin Genet, 2009, 75 (2) : 150 - 156.
  • 2HEUERTZ S, LE MERRER M, ZABEL B, et al. Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondro- plasia[ J ]. Eur J Hum Genet, 9006, 14 (12) : 1240 - 1247.
  • 3SUPERTI FURGA A,EICH G,BUCHER H U, et al. A glycine 375 to cysteine substitution in the transmembrane domain of the fi- broblast growth factor receptor 3 in a newborn with achondroplasia [J]. Eur J Pediatr, 1995, 154(3) : 215 -219.
  • 4IKEGAWA S, FUKUSHIMA Y, ISOMURA M, et al. Mutations of the fibroblast growth factor receptor 3 gene in one familial and six sporadic case of achondroplasia in Japanese patients [ J ]. Hum Genet, 1995, 96(3) : 309 -311.
  • 5BONAVENTURE J, ROUSSEAU F, LEGEAI MALLET L, et 81. Common mutations in the fibroblast growth factor receptor 3 ( FGFR 3) gene account for achoudroplasia, hypochondroplasia, and thanato- phoric dwarfism[J]. Am J Meal Genet, 1996, 63(1): 148-154.
  • 6ROUSSEAU F, BONAVENTURE J, LEGEAI MALLET L, et al. Clinical and genetic heterogeneityof hypochondroplasia[ J]. J MedGenet, 1996, 33(9): 749-752.
  • 7KATSUMATA N, MIKAMI S, NAGASHIMA MIYOKAWA A, et al. Analysis of the FGFR3 gene in Japanese patients with achon- droplasia and hypochondroplasia[J]. Endocr J, 2000, 47 Suppl : S121 - S124.
  • 8BELLUS G, SPECTOR E B, SPEISER P, et al. Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase ac- tivation and the severity of the skeletal dysplasia phenotype [ J ]. Am J Hum Genet, 2000, 67(6) : 1411 -1421.
  • 9WINTERPACHT A, HILBERT K, STELZER C, et al. A novel mutation in FGFR - 3 disrupts a putative N - glycosylation site and results in hypochondroplasia [ J ]. Physiol Gennmics, 2000, 2 (1): 9-12.
  • 10张晔.与FGFR3基因有关的遗传性侏儒研究进展[J].中国优生与遗传杂志,2000,8(1):1-3. 被引量:4

二级参考文献39

  • 1胡正茂,郑多,潘乾,杨一峰,赵天力,刘小平,邬玲仟,蒋冬贵,夏昆,夏家辉.EXT2基因IVS2+1G>A突变致遗传性多发性外生性骨疣[J].中华医学遗传学杂志,2004,21(2):97-100. 被引量:6
  • 2Sehmale GA, Conrad EU 3rd, Raskind WH. The natural history of hereditary multiple exostoses. J Bone Joint Surg Am, 1994, 76:986-992.
  • 3Wicklund CL, Pauli RM, Johnston D, et al. Natural history study of hereditary multiple exostoses. Am J Med Genet, 1995, 55:43-46.
  • 4Cook A, Raskind W, Blanton SH, et al. Genetic heterogeneity in families with hereditary multiple exostoses. Am J Hum Genet, 1993, 53:71-79.
  • 5Wu YQ, Heutink P, de Vries BB, et al. Assignment of a second locus for multiple exostoses to the perieentromerie region of chromosome 11. Hum Mol Genet, 1994, 3:167-171.
  • 6Le Merrer M, Legeai-Mallet L, Jeannin PM, et al. A gene for hereditary multiple exostoses maps to chromosome 19p. Hum Mol Genet , 1994, 3 :717-722.
  • 7Ahn J, Ludecke HJ, Lindow S, et al. Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXTI). Nat Genet, 1995,11 : 137-143.
  • 8Stickens D, Clines G, Burbee D, et al. The EXT2 multiple exostoses gene defines a family of putative turnout suppressor genes. Nat Genet, 1996,14:25-32.
  • 9Wuyts W, van Hul W, Wauters J, et al. Positional cloning of a gene involved in hereditary multiple exostoses. Hum Mol Genet, 1996, 5 : 1547-1557.
  • 10Zhang R, Zhu Z, Zhu H, et al. SNP cutter : a comprehensive tool for SNP PCR-RFLP assay design. Nucleic Acids Res, 2005, 33 (Web Server issue) : W489-492.

共引文献8

同被引文献19

  • 1ZHANG Shi-rong,ZHOU Xiao-qing,REN Xiang,WANG Tian-tian,YUAN Ming-xiong,WANG Qing,LIU Jing-yu,LIU Mu-gen.Ser217Cys mutation in the Ig Ⅱ domain of FGFR3 in a Chinese family with autosomal dominant achondroplasia[J].Chinese Medical Journal,2007(11):1017-1019. 被引量:9
  • 2Richette P, Bardin T, Stheneur C. Achondroplasia: from genotype to phenotype[J]. Joint Bone Spine, 2008, 75 (2) : 125-130.
  • 3Rousseau F, Bonaventure J, Legeai-Mallet L, et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia [J]. Nature,1994,371 (6494) : 252-254.
  • 4弗斯.临床遗传学[M].杭州:浙江大学出版社,2008:324-327.
  • 5Laederich MB, Horton WA. FGFR3 targeting strategies for achondro- plasia[ J]. Expert Rev Mol Med, 2012,14 : e11.
  • 6Foldynova-Trantirkova S, Wilcox WR, Krejci P. Sixteen years and counting: the current understanding of fibroblast growth factor recep- tor 3 ( FGFR3 ) signaling in skeletal dysplasias [ J ]. Hum Mutat, 2012, 33(1) : 29-41.
  • 7Ramaswami U, Hindmarsh PC, Brook CG. Growth hormone therapy in hypochondroplasia [ J ]. Acta Paediatr Suppl, 1999, 88 ( 428 ) : 116-117.
  • 8Castro-Feijoo L, Loidi L, Vidal A, et al. Hypochondroplasia and acanthosis nigricans: a new syndrome due to the p. Lys650Thr mu- tation in the fibroblast growth factor receptor 3 gene? [ J ]. Eur J Endocrinol, 2008, 159 ( 3 ) : 243-249.
  • 9Heuertz S, Le Merrer M, Zabel B, et al. Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia[ J]. Eur J Hum Genet, 2006, 14(12) : 1240-1247.
  • 10Vajo Z, Francomano CA, Wilkin DJ. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondre- plasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans [ J ]. Endocr Rev, 2000, 21(1): 23-39.

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部